Cash & equivalents decreased 26.8%
Cash & equivalents changed -26.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -26.8% from the comparable as-filed period.
Gross margin changed -8994 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross profit changed -8317.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed -59.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -68.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating margin changed -7098 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -95.8% from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes.
Net income changed -17.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Revenue changed -12.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.